Golden State Medical Supply recalls
Golden State Medical Supply appears in 55 official U.S. recall notices indexed by RecallRadar, most recently on 2026-09-09.
Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.
Recall summary
| Recall notices | 55 |
|---|---|
| Published | 2014-06-11 to 2026-09-09 |
| By agency | FDA Drug (55) |
| By classification | Class II (42), Class III (12), Class I (1) |
| By status | terminated (42), ongoing (13) |
| Distribution named in notices | AZ, GA, IA, IL, MA, MI, MN, MO, PA, TN, TX, US |
Recalls
- Prasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC: 51407-445-30
FDA Drug · Class II · 2026-09-09 · Golden State Medical Supply
Reason: Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution - Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, M…
FDA Drug · Class II · 2026-08-26 · Golden State Medical Supply
Reason: CGMP deviations: tablets with black specks. - GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured by Kremers Urban Pharmaceuticals Inc.,…
FDA Drug · Class II · 2026-06-17 · Golden State Medical Supply
Reason: Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specification (low) for stage 3 dissolution at the 24-hour timepoint. - Primidone Tablets, USP, 50 mg, 50-count bottle, RX only, Manufactured by: Lannett Company, Inc., Marketed by: GSMS, Incorporated, Camarillo…
FDA Drug · Class III · 2026-05-27 · Golden State Medical Supply
Reason: Cross contamination with other products: API contaminated with trace amounts of Acemetacin API. - Primidone Tablets, USP, 250 mg, 100-count bottle, RX only, Manufactured by: Lannett Company, Inc., Marketed by: GSMS, Incorporated, Camaril…
FDA Drug · Class III · 2026-05-27 · Golden State Medical Supply
Reason: Cross contamination with other products: API contaminated with trace amounts of Acemetacin API. - Baclofen Tablets USP, 10 mg, 1000-count bottles, Rx only, Marketed by: GSMS, Incorporated, CA 93012 USA. NDC 51407-973-10
FDA Drug · Class II · 2025-12-24 · Golden State Medical Supply
Reason: Presence of Foreign Tablets/Capsules - NIACIN Extended-Release Tablets, USP, 1,000 mg, 90 tablets per bottle, Rx only, Manufactured by: Kremers Urban Pharmaceuticals, Inc., a sub…
FDA Drug · Class II · 2025-11-26 · Golden State Medical Supply
Reason: Failed Dissolution Specifications - PRASUGREL TABLETS, 5 mg, 30 tablet bottles, Rx only, packaged by GSMS, Incorporated, Camarillo, CA 93012 NDC 51407-444-30
FDA Drug · Class II · 2025-03-26 · Golden State Medical Supply
Reason: Failed Dissolution Specifications - Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, a) 30 capsules bottles, NDC 60429-165-30
FDA Drug · Class II · 2024-07-03 · Golden State Medical Supply
Reason: CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the proposed interim limit. - Fluticasone Propionate Nasal Spray USP, 50 mcg per spray, 120 metered sprays, 16 g net fill, Rx only, Manufactured by: Apotek Inc., Toronto…
FDA Drug · Class II · 2024-03-06 · Golden State Medical Supply
Reason: CGMP Deviations:Suspected potential presence of Burkholderia cepacia complex - Budesonide Extended-Release Tablets, 9 mg, 30-count bottles, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA, UPC 5140782430, NDC 5…
FDA Drug · Class II · 2024-02-07 · Golden State Medical Supply
Reason: Failed Dissolution Specifications - PAROXETINE tablets, USP, 10 mg, Packaged as a) 30-count bottle, NDC 60429-734-30
FDA Drug · Class II · 2023-12-06 · Golden State Medical Supply
Reason: Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine - PAROXETINE tablets, USP, 40 mg, Packaged as a) 30-count bottle, NDC 60429-737-30
FDA Drug · Class II · 2023-12-06 · Golden State Medical Supply
Reason: Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine - PAROXETINE tablets, USP, 20 mg, Packaged as a) 90-count bottle NDC 60429-735-90
FDA Drug · Class II · 2023-12-06 · Golden State Medical Supply
Reason: Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine - Travoprost Ophthalmic Solution, USP (Ionic Buffered Solution), 0.004%, Rx only, Manufactured by Apotex Inc., Manufactured by: GSMS Incorpor…
FDA Drug · Class II · 2023-06-14 · Golden State Medical Supply
Reason: Lack of Assurance of Sterility: Tamper Evidence Seal is missing on secondary container. - Atenolol Tablets, USP, 25 mg, 1000-count bottle, Rx only, Manufactured by: ALPHAPHARM PTY LTD, Marketed by: GSMS, Incorporated, Camarillo,…
FDA Drug · Class I · 2022-11-02 · Golden State Medical Supply
Reason: Label Mix - up; a bottle labeled as Atenolol 25mg Tablets contained Clopidogrel 75mg Tablets - Rifampin Capsules, USP, 300 mg, packaged in a) 30-count bottle (NDC 51407-323-30), b) 60-count bottle (NDC 51407-323-60), c) 100-count bott…
FDA Drug · Class II · 2022-10-26 · Golden State Medical Supply
Reason: Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP). - Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Manufactured by Patheon Pharmaceuticals Inc., OH, Packaged by GSMS, Incorporated,…
FDA Drug · Class II · 2022-10-26 · Golden State Medical Supply
Reason: Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP). - Enalapril Maleate Tablets, USP
FDA Drug · Class II · 2022-07-13 · Golden State Medical Supply
Reason: CGMP Deviations - Enalapril Maleate Tablets, USP
FDA Drug · Class II · 2022-07-13 · Golden State Medical Supply
Reason: CGMP Deviations - Enalapril Maleate Tablets, USP
FDA Drug · Class II · 2022-07-13 · Golden State Medical Supply
Reason: CGMP Deviations - Enalapril Maleate Tablets, USP
FDA Drug · Class II · 2022-07-13 · Golden State Medical Supply
Reason: CGMP Deviations - Alprazolam Tablets, USP 1mg, 180-count bottles, Rx only, Manufactured by ULTRAlab Laboratories, Inc., NY
FDA Drug · Class II · 2022-03-23 · Golden State Medical Supply
Reason: CGMP Deviation: Potential cross-contamination with other drug substance during the manufacturing process. - Ezetimibe and Simvastatin Tablets, 10 mg/40mg, a) 90 Tablets, b) 500 tablets, Rx only, Manufactured by Dr. Reddy's Laboratories LA LLC Shre…
FDA Drug · Class II · 2021-11-17 · Golden State Medical Supply
Reason: Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in th… - Ezetimibe and Simvastatin Tablets, 10 mg/80mg, 500 tablet bottles, Rx only, Manufactured by Dr. Reddy's Laboratories LA LLC Shreveport, LA…
FDA Drug · Class II · 2021-11-17 · Golden State Medical Supply
Reason: Failed Excipient Specification; product manufactured using an excipient found to be OOS for conductivity - Omeprazole Delayed Release Capsules, USP, 20 mg, 1000-count bottles, Rx only, Packaged by GSMS Incorporated, Camarillo, CA 93012-8601 USA,…
FDA Drug · Class II · 2021-03-31 · Golden State Medical Supply
Reason: Failed Impurities/Degradation Specifications: Out of Specification results obtained for unknown impurities during stability testing by manufacturer - ARIPIPRAZOLE TABLETS, 15 mg, 30-count. bottles, Rx Only, GSMS Incorporated, Manufactured by: Apotex Inc
FDA Drug · Class II · 2020-12-09 · Golden State Medical Supply
Reason: FAILED DISSOLUTION SPECIFICATIONS: Possibility of out-of-specification (OOS) dissolution limits for the remaining shelf life of the Aripiprazole Tablets - Clobetasol Propionate Cream, USP, 0.05%, packaged in a)15g Tubes (NDC 60429-902-15) and b) 45g Tubes (NDC 60429-902-45), Rx Only, Mfd. by:…
FDA Drug · Class III · 2020-08-19 · Golden State Medical Supply
Reason: Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity. - Losartan Potassium Tablets, USP, 25 mg, Rx only, a) 30 ct. (NDC 60429-316-30) b) 90ct. (NDC 60429-316-90) c) 1,000 ct. (60429-316-10) bottl…
FDA Drug · Class II · 2020-04-22 · Golden State Medical Supply
Reason: CGMP Deviations: Impurity for N-nitroso-N-methyl-4-aminobutryric Acid (NBMA) detected in active ingredient (API) used to manufacture finished products. - TRAMADOL HYDROCHLORIDE Tablets, USP, 50 mg, Rx Only a)100-count bottles (NDC 60429-588-01) b) 500-count bottle (NDC 60429-588-05) Manufactu…
FDA Drug · Class III · 2020-03-04 · Golden State Medical Supply
Reason: Labeling: Incorrect package insert - Patient leaflets for the specified lots of unscored tablets contain language relative to a 25 mg dosing titration that necessitates the use of a scored 50 mg tablet. - GSMS: Ranitidine Capsules 300 mg, Rx only, 100 count bottles (NDC 51407-098-01) Manufactured by Novitium Pharma LLC, 70 Lake Drive, East Wi…
FDA Drug · Class II · 2019-11-20 · Golden State Medical Supply
Reason: CGMP Deviations: Presence of NDMA impurity detected in product. - GSMS: Ranitidine Capsules 150 mg, Rx only, 500 count bottles (NDC 51407-097-05) Manufactured by Novitium Pharma LLC, 70 Lake Drive, East Wi…
FDA Drug · Class II · 2019-11-20 · Golden State Medical Supply
Reason: CGMP Deviations: Presence of NDMA impurity detected in product. - Losartan Potassium, 50 mg tablets, 1000 count bottle, NDC 60429-317-10
FDA Drug · Class II · 2019-07-17 · Golden State Medical Supply
Reason: CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products. - Losartan Potassium, 50 mg tablets, 90 count bottle, NDC 60429-317-90
FDA Drug · Class II · 2019-07-17 · Golden State Medical Supply
Reason: CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products. - Losartan Potassium, 50 mg tablets, 30 count bottle, NDC 60429-317-30
FDA Drug · Class II · 2019-07-17 · Golden State Medical Supply
Reason: CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products. - Losartan Potassium, 100 mg tablets, 90 count bottle, NDC 60429-318-90
FDA Drug · Class II · 2019-07-17 · Golden State Medical Supply
Reason: CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products. - Losartan Potassium Tablets USP 25 mg 1000 count bottle NDC 60429-316-10 Rx only GSMS Incorporated
FDA Drug · Class II · 2019-05-29 · Golden State Medical Supply
Reason: CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer - Losartan Potassium Tablets USP 100 mg 1000 count bottle NDC 60429-318-10 Rx only GSMS Incorporated
FDA Drug · Class II · 2019-05-29 · Golden State Medical Supply
Reason: CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer - Losartan Potassium Tablets USP 25 mg 30 count bottle NDC 60429-316-30 Rx only GSMS Incorporated
FDA Drug · Class II · 2019-05-29 · Golden State Medical Supply
Reason: CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer - Losartan Potassium Tablets USP 100 mg 90 count bottle NDC 60429-318-90 Rx only GSMS Incorporated
FDA Drug · Class II · 2019-05-29 · Golden State Medical Supply
Reason: CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer - Losartan Potassium Tablets USP 25 mg 90 count bottle NDC 60429-316-90 Rx only GSMS Incorporated
FDA Drug · Class II · 2019-05-29 · Golden State Medical Supply
Reason: CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer - IRBESARTAN Tablets, USP 150 mg (a) 30-count bottle (NDC 60429-641-30), (b) 90-count bottle (NDC 60429-641-90) Rx Only, Manufactured by: Sci…
FDA Drug · Class II · 2018-11-28 · Golden State Medical Supply
Reason: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodiethylamine (NDEA) in product. - IRBESARTAN Tablets, USP 300 mg (a) 30-count bottle (NDC 60429-642-30), (b) 90-count bottle (NDC 60429-642-90) Rx Only, Manufactured by: Sci…
FDA Drug · Class II · 2018-11-28 · Golden State Medical Supply
Reason: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodiethylamine (NDEA) in product. - IRBESARTAN Tablets, USP 75 mg 90-count bottle, Rx Only, Manufactured by: SciGen Pharmaceuticals, Inc
FDA Drug · Class II · 2018-11-28 · Golden State Medical Supply
Reason: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodiethylamine (NDEA) in product. - Venlafaxine Hydrochloride Extended-Release Capsules, 150 mg, a) 30 capsules per bottle, NDC # 60429-123-30, b) 90 capsules per bottle, NDC…
FDA Drug · Class II · 2016-08-24 · Golden State Medical Supply
Reason: Failed Dissolution Specifications: Out-of-specification results in retained sample. - Venlafaxine Hydrochloride Extended-Release Capsules, 75 mg, 90 capsules per bottle, Rx Only, GSMS, NDC # 60429-122-90
FDA Drug · Class II · 2016-08-24 · Golden State Medical Supply
Reason: Failed Dissolution Specifications: Out-of-specification results in retained sample. - DULOXETINE Delayed-Release Capsules, USP, 60 mg, 1000 count bottles, Rx only, Manufactured by: Laboratorios del Dr. Esteve, SA, Martorelles…
FDA Drug · Class III · 2016-07-20 · Golden State Medical Supply
Reason: Labeling; Incorrect or Missing Lot and/or Exp Date; incorrect expiration date on container label is 02/2019, correct expiration date should be 02/2018 - Atorvastatin Calcium 40 mg, 10 tablets per blister,100-count package, Rx Only Manufactured by Apotex Inc
FDA Drug · Class III · 2016-03-16 · Golden State Medical Supply
Reason: Failed Impurities/Degradation Specifications - Atorvastatin Calcium 80 mg, 10 tablets per blister,100-count package, Rx Only Manufactured by Apotex Inc
FDA Drug · Class III · 2016-03-16 · Golden State Medical Supply
Reason: Failed Impurities/Degradation Specifications - Atorvastatin Calcium 10 mg, 10 tablets per blister,100-count package, Rx Only Manufactured by Apotex Inc
FDA Drug · Class III · 2016-03-16 · Golden State Medical Supply
Reason: Failed Impurities/Degradation Specifications